New stomach cancer strategy: attack tumor and infection together
NCT ID NCT06510010
Summary
This study is testing if adding treatment for a common stomach bacteria (H. pylori) to standard chemotherapy works better for patients with locally advanced stomach cancer. About 200 participants will receive chemotherapy before and after surgery. Half will also get the H. pylori treatment starting with their first chemo cycle, while the other half will get it later after surgery. Researchers will compare how much the tumor shrinks and how long patients live without the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Sixth Affiliated Hospital，Sun Yat-sen University
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.